BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Merck’s Molnupiravir Sheds Efficacy Points Ahead of Key FDA Meeting

  The latest data from Merck and Ridgeback Biotherapeutics’ MOVe-OUT trial on the use of molnupiravir to treat COVID-19 in adults has shown a lower efficacy than previously reported.

  November 29, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Turnstone and Moffitt Cancer Center Team Up on TILs

  New York-based Turnstone Biologics announced it is partnering with the Moffitt Cancer Center to develop tumor-infiltrating lymphocyte (TIL) therapies.

  November 29, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Omicron Variant has Vaccine Makers Moving Fast and More COVID News

  Omicron has caused the U.S. to install travel bans against several South African countries while vaccine makers rush to test their vaccines against it. For that news and more, continue reading.

  November 29, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  FDA

  Sigilon Uncovers Possible Reason Behind Hemophilia A Trial Hold

  Sigilon Therapeutics announced it may have discovered the reason why its experimental cell therapy treatment for severe hemophilia A was placed on clinical hold by the FDA.

  November 29, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Promising Signals Emerge from Two Phase II Cancer Studies

  Two biopharma companies developing therapeutics in the oncology space begin the week with strong signals in Phase II.

  November 29, 2021

   · 

  3 min read

   · 

  Rose Alba
• 

  Career Advice

  Doctor Careers in Pharma: Everything You Need to Know

  Are you looking for doctor careers in the pharma sector? Here is everything you need to know about how you can choose a reputable and growing pharma career.

  November 29, 2021

   · 

  5 min read

   · 

  Alina Zahid
• 

  Drug Development

  Talaris is Rapidly Expanding as it Speeds Toward a First BLA

  As the late-stage trials continue to progress, Talaris is rapidly ramping up its resources and investments.

  November 29, 2021

   · 

  7 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Early-Stage Diabetes Treatment Wows Patients and Clinicians Alike

  In October, Vertex Pharmaceuticals announced stunning results in a type 1 diabetes patient who had been dosed with the company’s experimental therapy.

  November 29, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  VYJUVEK: Gene-Based Therapy for Rare Skin Disease Succeeds in Phase III

  Results from its GEM-3 trial on VYJUVEK demonstrated statistical significance in its ability to promote complete wound healing within six months compared to a placebo.

  November 29, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Genetown

  Boston Neighbors Net $256 Million for Treg and Allosteric Therapies

  Quell Therapeutics scooped up $156 million in a Series B round this week. The company utilizes regulatory T cells to treat a variety of autoimmune and inflammatory diseases.

  November 29, 2021

   · 

  3 min read

   · 

  Kate Goodwin